Lacosamide monotherapy for the treatment of childhood epilepsy with centrotemporal spikes was well tolerated and resulted in significantly reduced seizures, according to a study published in Brain and Development.
“Childhood epilepsy with centrotemporal spikes is an age-limited epilepsy syndrome,” Tohru Okanishi, MD, PhD, associate professor of child neurology at Tottori University in Japan, and colleagues wrote. “Although the use of antiepileptic drugs is not always recommended, the frequency of seizures, daytime seizures or the evolution to bilateral tonic-clonic seizures